Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. / Fabbrini, Elisa; Mohammed, B Selma; Magkos, Faidon; Korenblat, Kevin M; Patterson, Bruce W; Klein, Samuel.

I: Gastroenterology, Bind 134, Nr. 2, 2008, s. 424-431.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Fabbrini, E, Mohammed, BS, Magkos, F, Korenblat, KM, Patterson, BW & Klein, S 2008, 'Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease', Gastroenterology, bind 134, nr. 2, s. 424-431. https://doi.org/10.1053/j.gastro.2007.11.038

APA

Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008). Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology, 134(2), 424-431. https://doi.org/10.1053/j.gastro.2007.11.038

Vancouver

Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology. 2008;134(2):424-431. https://doi.org/10.1053/j.gastro.2007.11.038

Author

Fabbrini, Elisa ; Mohammed, B Selma ; Magkos, Faidon ; Korenblat, Kevin M ; Patterson, Bruce W ; Klein, Samuel. / Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. I: Gastroenterology. 2008 ; Bind 134, Nr. 2. s. 424-431.

Bibtex

@article{9a70eef740a9425bb6505222d1c91d91,
title = "Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease",
abstract = "Background & aims: Steatosis in patients with nonalcoholic fatty liver disease (NAFLD) is due to an imbalance between intrahepatic triglyceride (IHTG) production and export. The purpose of this study was to evaluate TG metabolism in adipose tissue and liver in NAFLD.Methods: Fatty acid, VLDL-TG, and VLDL-apolipoprotein B-100 (apoB100) kinetics were assessed by using stable isotope tracers in 14 nondiabetic obese subjects with NAFLD (IHTG, 22.7% +/- 2.0%) and 14 nondiabetic obese subjects with normal IHTG content (IHTG, 3.4% +/- 0.4%), matched on age, sex, body mass index, and percent body fat.Results: Compared with the normal IHTG group, the NAFLD group had greater rates of palmitate release from adipose tissue into plasma (85.4 +/- 6.6 and 114.1 +/- 8.1 micromol/min, respectively; P = .01) and VLDL-TG secretion (11.4 +/- 1.1 and 24.3 +/- 3.1 micromol/min, respectively; P = .001); VLDL-apoB100 secretion rates were not different between groups. The increase in VLDL-TG secretion was primarily due to an increased contribution from {"}nonsystemic{"} fatty acids, presumably derived from lipolysis of intrahepatic and intra-abdominal fat and de novo lipogenesis. VLDL-TG secretion rate increased linearly with increasing IHTG content in subjects with normal IHTG but reached a plateau when IHTG content was >/=10% (r = 0.618, P < .001).Conclusions: Obese persons with NAFLD have marked alterations in both adipose tissue (increased lipolytic rates) and hepatic (increased VLDL-TG secretion) TG metabolism. Fatty acids derived from nonsystemic sources are responsible for the increase in VLDL-TG secretion. However, the increase in hepatic TG export is not adequate to normalize IHTG content.",
keywords = "Adipose Tissue/metabolism, Adult, Apolipoprotein B-100/metabolism, Body Composition/physiology, Case-Control Studies, Fatty Acids/metabolism, Fatty Liver/complications, Female, Humans, Lipid Metabolism/physiology, Lipoproteins/metabolism, Lipoproteins, VLDL/metabolism, Liver/metabolism, Male, Middle Aged, Obesity/complications, Triglycerides/metabolism",
author = "Elisa Fabbrini and Mohammed, {B Selma} and Faidon Magkos and Korenblat, {Kevin M} and Patterson, {Bruce W} and Samuel Klein",
note = "(Ekstern)",
year = "2008",
doi = "10.1053/j.gastro.2007.11.038",
language = "English",
volume = "134",
pages = "424--431",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease

AU - Fabbrini, Elisa

AU - Mohammed, B Selma

AU - Magkos, Faidon

AU - Korenblat, Kevin M

AU - Patterson, Bruce W

AU - Klein, Samuel

N1 - (Ekstern)

PY - 2008

Y1 - 2008

N2 - Background & aims: Steatosis in patients with nonalcoholic fatty liver disease (NAFLD) is due to an imbalance between intrahepatic triglyceride (IHTG) production and export. The purpose of this study was to evaluate TG metabolism in adipose tissue and liver in NAFLD.Methods: Fatty acid, VLDL-TG, and VLDL-apolipoprotein B-100 (apoB100) kinetics were assessed by using stable isotope tracers in 14 nondiabetic obese subjects with NAFLD (IHTG, 22.7% +/- 2.0%) and 14 nondiabetic obese subjects with normal IHTG content (IHTG, 3.4% +/- 0.4%), matched on age, sex, body mass index, and percent body fat.Results: Compared with the normal IHTG group, the NAFLD group had greater rates of palmitate release from adipose tissue into plasma (85.4 +/- 6.6 and 114.1 +/- 8.1 micromol/min, respectively; P = .01) and VLDL-TG secretion (11.4 +/- 1.1 and 24.3 +/- 3.1 micromol/min, respectively; P = .001); VLDL-apoB100 secretion rates were not different between groups. The increase in VLDL-TG secretion was primarily due to an increased contribution from "nonsystemic" fatty acids, presumably derived from lipolysis of intrahepatic and intra-abdominal fat and de novo lipogenesis. VLDL-TG secretion rate increased linearly with increasing IHTG content in subjects with normal IHTG but reached a plateau when IHTG content was >/=10% (r = 0.618, P < .001).Conclusions: Obese persons with NAFLD have marked alterations in both adipose tissue (increased lipolytic rates) and hepatic (increased VLDL-TG secretion) TG metabolism. Fatty acids derived from nonsystemic sources are responsible for the increase in VLDL-TG secretion. However, the increase in hepatic TG export is not adequate to normalize IHTG content.

AB - Background & aims: Steatosis in patients with nonalcoholic fatty liver disease (NAFLD) is due to an imbalance between intrahepatic triglyceride (IHTG) production and export. The purpose of this study was to evaluate TG metabolism in adipose tissue and liver in NAFLD.Methods: Fatty acid, VLDL-TG, and VLDL-apolipoprotein B-100 (apoB100) kinetics were assessed by using stable isotope tracers in 14 nondiabetic obese subjects with NAFLD (IHTG, 22.7% +/- 2.0%) and 14 nondiabetic obese subjects with normal IHTG content (IHTG, 3.4% +/- 0.4%), matched on age, sex, body mass index, and percent body fat.Results: Compared with the normal IHTG group, the NAFLD group had greater rates of palmitate release from adipose tissue into plasma (85.4 +/- 6.6 and 114.1 +/- 8.1 micromol/min, respectively; P = .01) and VLDL-TG secretion (11.4 +/- 1.1 and 24.3 +/- 3.1 micromol/min, respectively; P = .001); VLDL-apoB100 secretion rates were not different between groups. The increase in VLDL-TG secretion was primarily due to an increased contribution from "nonsystemic" fatty acids, presumably derived from lipolysis of intrahepatic and intra-abdominal fat and de novo lipogenesis. VLDL-TG secretion rate increased linearly with increasing IHTG content in subjects with normal IHTG but reached a plateau when IHTG content was >/=10% (r = 0.618, P < .001).Conclusions: Obese persons with NAFLD have marked alterations in both adipose tissue (increased lipolytic rates) and hepatic (increased VLDL-TG secretion) TG metabolism. Fatty acids derived from nonsystemic sources are responsible for the increase in VLDL-TG secretion. However, the increase in hepatic TG export is not adequate to normalize IHTG content.

KW - Adipose Tissue/metabolism

KW - Adult

KW - Apolipoprotein B-100/metabolism

KW - Body Composition/physiology

KW - Case-Control Studies

KW - Fatty Acids/metabolism

KW - Fatty Liver/complications

KW - Female

KW - Humans

KW - Lipid Metabolism/physiology

KW - Lipoproteins/metabolism

KW - Lipoproteins, VLDL/metabolism

KW - Liver/metabolism

KW - Male

KW - Middle Aged

KW - Obesity/complications

KW - Triglycerides/metabolism

U2 - 10.1053/j.gastro.2007.11.038

DO - 10.1053/j.gastro.2007.11.038

M3 - Journal article

C2 - 18242210

VL - 134

SP - 424

EP - 431

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -

ID: 290676569